Sigma HealthcareSIGGF 59 Piotroski F-Score is 3 as of Jun. 24, 2026, which is 50% below its 10-year median of 6.00. GuruFocus rates SIGGF with a GF Score™ of 59/100 and a GF Value™ of $0.31. The stock has 8 warning signs investors should review. Among 114 Medical Distribution companies, Sigma Healthcare ranks worse than 81.58% on this metric.
Warning Sign:
Piotroski F-Score of 3 is low, which usually implies poor business operation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Sigma Healthcare has an F-score of 3. It is a bad or low score, which usually implies poor business operation.
The historical rank and industry rank for Sigma Healthcare's Piotroski F-Score or its related term are showing as below:
SIGGF'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 6 Max: 7
Current: 3
During the past 13 years, the highest Piotroski F-Score of Sigma Healthcare was 7. The lowest was 3. And the median was 6.
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Sigma Healthcare Piotroski F-Score Related Terms
Sigma Healthcare Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Sigma Healthcare's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SIGGF vs MCK, COR, CAH: Piotroski F-Score Comparison
For the Medical Distribution subindustry, Sigma Healthcare's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sigma Healthcare Piotroski F-Score vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Sigma Healthcare's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Sigma Healthcare's current Net Income (TTM) was -9.
==> Negative ==> Score 0.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Sigma Healthcare's return on assets of this year was -0.0105509. Sigma Healthcare's return on assets of last year was 0.00333888.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Sigma Healthcare's gearing of this year was 0.09692423. Sigma Healthcare's gearing of last year was 0.17373522.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Sigma Healthcare's current ratio of this year was 2.45771807. Sigma Healthcare's current ratio of last year was 1.43676177.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Sigma Healthcare's number of shares in issue this year was 1571.64. Sigma Healthcare's number of shares in issue last year was 1024.448.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Sigma Healthcare's gross margin of this year was 0.06026815. Sigma Healthcare's gross margin of last year was 0.08053009.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Sigma Healthcare's asset turnover of this year was 3.69875491. Sigma Healthcare's asset turnover of last year was 2.49975673.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
0
+
0
+
0
+
0
+
1
+
1
+
0
+
0
+
1
=
3
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Sigma Healthcare has an F-score of 3. It is a bad or low score, which usually implies poor business operation.
Sigma Healthcare (SIGGF) has a Piotroski F-Score of 3 as of Jun. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Sigma Healthcare and its competitors. This is 50% below median its historical median of 6.00. Over the past decade, Sigma Healthcare's Piotroski F-Score has ranged from 3.00 to 7.00. According to the industry distribution chart, Sigma Healthcare ranks #93 out of 114 companies in the Medical Distribution industry, placing it in the top 81.6%.
Is Sigma Healthcare's Piotroski F-Score too high?
Sigma Healthcare's current Piotroski F-Score of 3 is 50% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 7.00. The Medical Distribution industry median Piotroski F-Score is 5.00. Sigma Healthcare's value of 3 is 40% below this industry median. Based on the distribution chart, Sigma Healthcare ranks #93 out of 114 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Sigma Healthcare has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's Piotroski F-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sigma Healthcare ranks #93 out of 114 companies for Piotroski F-Score. This places Sigma Healthcare in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Sigma Healthcare's value of 3 is 40% below this benchmark. Historically, Sigma Healthcare's own Piotroski F-Score has ranged from 3.00 to 7.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Sigma Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Distribution company?
The median Piotroski F-Score among Medical Distribution companies is 5.00, based on 114 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sigma Healthcare's current Piotroski F-Score of 3 is 40% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Sigma Healthcare and its competitors. For the Medical Distribution industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sigma Healthcare's current Piotroski F-Score is 3, which is 50% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Sigma Healthcare (SIGGF) has a current Piotroski F-Score of 3. The stock's GF Value™ is $0.31, compared to a current price of $2.35 — trading 657.4% above its estimated fair value. The current Piotroski F-Score is 3, which is 50% below median its 10-year median of 6.00 and 40% below the Medical Distribution industry median of 5.00. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Sigma Healthcare (SIGGF), the current Piotroski F-Score is 3 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sigma Healthcare (SIGGF) Overvalued in 2026?
Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued.
The current stock price of $2.35 is trading 657.4% above its estimated GF Value™ of $0.31.
Key valuation signals for SIGGF:
Piotroski F-Score: 3 (50% below median its 10-year median of 6.00)
GF Value™: $0.31 vs. price of $2.35 (657.4% above fair value)
Industry Position: 40% below the Medical Distribution median (#93 of 114)
No single metric tells the full story. See the SIGGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score
Get the complete analysis for SIGGF
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SIGGF has been successfully added to your 
